Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.

Neuroscience letters - 31 Dec 2009

Wang Yong, Wang Xuan, Liu Limin, Wang Xiaomin

Abstract excerpt

Histone deacetylase (HDAC) inhibitors have been shown associated with neurodegenerative diseases. However, their effects on survival of dopaminergic neurons remain uncertain. In the present study, the HDAC inhibitor trichostatin A (TSA) was tested in following dopaminergic neuronal cell lines: rat N27, mouse MN9D, and human SH-SY5Y cells. Results demonstrated that a single TSA treatment resulted in decreased cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Drug Evaluation, Preclinical
Share to Histone Deacetylase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histone Deacetylases

Share to Hydroxamic Acids

Share to Nerve Degeneration

Share to Rotenone

Share to Substantia Nigra

Source

Identifiers

PMID: 19835929
DOI: 10.1016/j.neulet.2009.10.037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.PMID 19835929Read ↗

Histone deacetylases as targets for the treatment of human neurodegenerative diseasesSemantic proximity Read ↗

Targeting Histone Deacetylases: A Novel Approach in Parkinson’s DiseaseSemantic proximity Read ↗

Synergistic effect of trichostatin A and 5‐aza‐2′‐deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: A proteomic studySemantic proximity Read ↗

Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell linesSemantic proximity Read ↗

Rationale for the Use of Histone Deacetylase Inhibitors as a Dual Therapeutic Modality in Multiple SclerosisSemantic proximity Read ↗

Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptideSemantic proximity Read ↗

Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy.Semantic proximity Read ↗

Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux.Semantic proximity Read ↗

Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.Semantic proximity Read ↗

Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple SclerosisSemantic proximity Read ↗

Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cellsSemantic proximity Read ↗

The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.